CALQUENCE® (acalabrutinib) Perspectives: Dr Andre Goy, MD Published 2023-12-18 Download video MP4 360p Download video MP4 720p Similar videos 00:12 Save The Date For AZ’s first Zoom Experience – Calquence Launch, AZ 03:46 Acalabrutinib for Treating Mantle Cell Lymphoma 01:33 BTK Inhibitors Improve Responses Relapsed/Refractory Mantle Cell Lymphoma 10:42 Understanding Mantle Cell Lymphoma with Jia Ruan, MD, Ph.D. 21:57 Part 5 - Clinical World Experience with Acalabrutinib in management of R/R CLL - Prof. Paolo Ghia 03:19 FDA-Approved Agents for the Treatment of MCL 02:02 CAR T-Cells in the Treatment Landscape of Mantle Cell Lymphoma 01:04 John P. Leonard, MD discusses lenalidomide plus rituximab for the treatment of MCL More results